Italy· 046927075
RXULTI*28 cpr rivestite 4 mg
A medicinal product containing brexpiprazolo, registered in Italy by OTSUKA PHARMACEUT.NETHER.BV, on the national reimbursement list.
Checked against the register on
Informational only — not a medical device.
The record
At a glance
- Active substance
- Brexpiprazolo
- Manufacturer
- OTSUKA PHARMACEUT.NETHER.BV
- Country
- Italy (IT)
- ATC code
- —
- Reimbursed
- Yes
- Last checked
- June 4, 2026
Packs & prices · 1
1 priced- aic046927075RXULTI*28 cpr rivestite 4 mgEUR 84.73
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Brexpiprazolo in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesBrexpiprazoleAjanta Pharma USA Inc.
- FinlandRxultiOtsuka Pharmaceutical Netherlands B.V.
- CzechiaRXULTIOtsuka Pharmaceutical Netherlands B.V., Amsterdam
- NorwayRxultiAbacus Medicine A/S
- BelgiumRxulti 0.25 mgOtsuka Pharmaceutical Netherlands
- IcelandRxultiOtsuka Pharmaceutical Netherlands B.V.*
- CanadaREXULTIOTSUKA PHARMACEUTICAL CO LTD
- SwitzerlandRexulti 0.5 mg, FilmtablettenLundbeck (Schweiz) AG
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Rxulti
- Liechtenstein · Rxulti
- Norway · Rxulti
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of the issuing authority. This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d14b96b2-c9a7-462a-a554-981a4533bc76 GET /v1/drugs/d14b96b2-c9a7-462a-a554-981a4533bc76?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"price": 84.73,
"source": "aifa",
"currency": "EUR",
"strength": "BREXPIPRAZOLO 4MG 28 UNITA' USO ORALE",
"substance": "Brexpiprazolo",
"equivalence_group": "LEK",
"transparency_flag": null
}See everything about brexpiprazolo.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.